ArticleJournal of computer assisted tomography
Four-dimensional Computed Tomography Imaging in Primary Hyperparathyroidism: Multireader Multicase Study of Both Neuroradiologists and General Radiologists of Imaging Approaches With Less Phases.
Article in Journal of computer assisted tomography. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePrimary hyperparathyroidism (PHPT) is commonly caused by parathyroid adenomas (PAs), and four-dimensional computed tomography (4DCT) is increasingly used for localising PAs due to its high sensitivity and specificity. However, the relative high radiation dose of 4DCT may limit its widespread use as first line imaging in some settings. A reduced phase protocol and enhancement maps, which highlight relative enhancement differences between the nonenhanced and arterial phases, have been proposed as ways to reduce radiation exposure without compromising diagnostic accuracy. This study aims to assess whether reduced 4DCT protocols can maintain diagnostic performance and if the enhancement map can further assist in adenoma localisation.
methodsThis retrospective study included 27 PHPT patients, with both single and double adenomas, and some ectopic cases and 3 secondary HPT patients. Five-phase combinations derived from our institution's 4-phase protocol were evaluated using a multireader, multicase approach involving experienced neuroradiologists and general radiologists. The phases tested included combinations of nonenhanced, arterial, venous, and delayed venous phases. An enhancement map was introduced as one of the phases. Readers were asked to identify adenomas and assign confidence levels. Performance metrics, including sensitivity, specificity, and area under the curve (AUC), were calculated, and noninferiority tests compared the results to the current 4-phase protocol.
resultsSensitivity of the total group was between 0.64 and 0.70 with a specificity between 0.94 and 0.97. AUC were between 0.80 and 0.84. All reduced phase combinations were noninferior to the 4-phase protocol. Neuroradiologists achieved noninferior results with 1-phase to 3-phase protocols, while general radiologists required at least 3-phases. The enhancement map did not improve sensitivity or specificity, although readers found it useful as a supplementary tool for identifying lesions. Artefacts, especially in ectopic locations, reduced its effectiveness.
conclusionsThis study supports the use of reduced 4DCT protocols for PHPT. A 1-phase or 2-phase protocol is recommended for experienced radiologists, while a 3-phase protocol is suitable for less experienced radiologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.